What is the recommended initial dose and titration schedule for starting someone on Paxil (paroxetine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Paxil (Paroxetine): Dosing and Titration Guide

Initial Dosing by Indication

For major depressive disorder, start paroxetine at 20 mg once daily in the morning, taken with or without food. 1 This is both the recommended starting dose and the minimum effective dose for depression. 1, 2

For panic disorder, start at 10 mg once daily in the morning, with a target dose of 40 mg/day. 1 The lower starting dose for panic disorder is critical because patients with panic disorder may experience initial anxiety activation with higher starting doses. 3

For obsessive-compulsive disorder (OCD), start at 20 mg once daily, with a target therapeutic dose of 40 mg/day. 1 The therapeutic range for OCD extends from 20-60 mg/day, with 40 mg/day being the recommended target. 1

For social anxiety disorder, generalized anxiety disorder, and PTSD, start at 20 mg once daily in the morning. 1 This is both the starting and established effective dose for these conditions. 1

Titration Schedule

Increase the dose in 10 mg increments at intervals of at least 1 week if the initial dose is insufficient. 1, 2 This weekly interval is essential to allow steady-state plasma concentrations to be achieved, which takes 7-14 days due to paroxetine's 24-hour half-life and saturable first-pass metabolism. 4

The maximum dose is 50 mg/day for depression and 60 mg/day for anxiety disorders (OCD, panic disorder, social anxiety disorder). 1 For most patients with depression, 20 mg/day will be the optimal dose, and only those not responding adequately should have doses increased. 1, 2

Special Populations

For elderly patients, debilitated patients, or those with severe renal or hepatic impairment, start at 10 mg once daily and do not exceed 40 mg/day. 1 These populations have higher plasma concentrations and slower elimination of paroxetine. 4

Timing and Administration

Administer as a single daily dose, usually in the morning, with or without food. 1 The 24-hour elimination half-life supports once-daily dosing. 4

Monitoring Timeline

Assess response after 1-3 weeks of treatment at the initial dose before considering dose escalation. 2 For depression, the full therapeutic effect may be delayed, which is consistent with the adaptive changes in serotonergic autoreceptors that occur with repeated administration. 3, 4

Continue monitoring monthly until symptoms are stabilized, then periodically reassess the need for continued treatment. 1 Long-term maintenance has been demonstrated effective for up to 1 year in depression and 6 months to 1 year in anxiety disorders. 5, 6

Common Pitfalls to Avoid

Do not increase doses more frequently than weekly intervals. 1 Paroxetine exhibits saturable metabolism and nonlinear pharmacokinetics with dose increases, requiring adequate time between adjustments. 4

Do not start at 20 mg in patients with panic disorder. 1 The 10 mg starting dose is specifically recommended to minimize initial anxiety activation. 3

Do not combine with MAOIs or start within 14 days of MAOI discontinuation due to serotonin syndrome risk. 1 Similarly, allow at least 14 days after stopping paroxetine before starting an MAOI. 1

Expected Adverse Effects

Counsel patients about common side effects: nausea (most common), sexual dysfunction, somnolence, headache, dry mouth, constipation, dizziness, sweating, and tremor. 5, 6, 3 These are generally mild and often diminish with continued treatment. 5

Paroxetine is generally better tolerated than tricyclic antidepressants and has a similar tolerability profile to other SSRIs. 5, 6 It is safer in overdose than tricyclics and lacks the dependence potential of benzodiazepines. 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.